Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection-Reference-Cited by-同舟云学术

Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection

Published:2013-01 Issue:1 Volume:56 Page:13-18
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Martín-Gandul C.,Pérez-Romero P.,Sánchez M.,Bernal G.,Suárez G.,Sobrino M.,Merino L.,Cisneros J.M.,Cordero E.

Funder

Ministerio de Economía y Competitividad, Instituto de Salud Carlos III

European Development Regional Fund

REIPI RD06/0008

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference40 articles.

1. Cytomegalovirus;Am J Transplant,2004

2. Monitoring human cytomegalovirus infection in transplant recipients;Baldanti;J Clin Virol,2008

3. Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review;Sun;Am J Transplant,2008

4. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation;Humar;Am J Transplant,2006

5. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation;Kotton;Transplantation,2010

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical guide to real‐world implementation of pre‐emptive therapy for Cytomegalovirus disease prevention in high‐risk seronegative liver transplant recipients with seropositive donors;Transplant Infectious Disease;2024-01-12

2. QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients;Transplantation;2023-11-22

3. Altered Signatures of Plasma Inflammatory Proteins and Phonotypic Markers of NK Cells in Kidney Transplant Patients upon CMV Reactivation;Current Microbiology;2022-11-29

4. Cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: clinical significance and definitions;Transplantologiya. The Russian Journal of Transplantation;2022-06-14

5. Incidence of Cytomegalovirus disease and viral replication kinetics in seropositive liver transplant recipients managed under preemptive therapy in a tertiary-care center in Mexico City: a retrospective cohort study;BMC Infectious Diseases;2022-02-14